Advanced search
Companies (34)
Ingersoll Rand Inc. specializes in the design, manufacture and marketing of industrial technological equipment. The group provides compressed air equipment (screw compressors, reciprocating compressors, centrifugal compressors, air dryers, air filters, et ...
Capitalization | 37 539 M USD |
---|---|
Change | +1.14% |
1-year price change | +20.31% |
International Star, Inc. operates, through its wholly owned subsidiary, Budding Equity Inc., a royalty-based business that owns intellectual property contracts with movie studios, which provide for the licensing of that intellectual property (IP) to third ...
Capitalization | 4 M USD |
---|---|
Change | +10.47% |
1-year price change | +533.33% |
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directe ...
Capitalization | 5 033 M USD |
---|---|
Change | +4.73% |
1-year price change | +2.07% |
CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (C ...
Capitalization | 157 M USD |
---|---|
Change | -28.97% |
1-year price change | -19.08% |
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for treatment of metabolic and endocrine disorders. The Company's clinical programs include VK2809, an orally available, small molecule ...
Capitalization | 6 865 M USD |
---|---|
Change | +0.78% |
1-year price change | +234.55% |
Ascletis Pharma Inc is a China-based investment holding company principally engaged in the research, development, production, marketing and sales of pharmaceutical products. The Company mainly focuses on viral diseases, non-alcoholic steatohepatitis (NASH ...
Capitalization | 157 M USD |
---|---|
Change | -0.82% |
1-year price change | -17.12% |
Nash Dom Bulgaria Holding AD Sofia (Nash Dom-Bulgaria AD-Holding or Nash Dom Bulgaria Holding PLC) is a Bulgaria-based holding company that is principally engaged in the acquisition, appraisal and managing of shares in companies active in the food process ...
Capitalization | 185 428 USD |
---|---|
Change | +17.31% |
1-year price change | -.--% |
Poxel is a biopharmaceutical company specializing in developing innovative treatments for metabolic diseases, including non-alcoholic steatohepatitis (NASH) and rare diseases. TWYMEEG® (Imeglimine), Poxel's lead product and the first in its class of medi ...
Capitalization | 32 M USD |
---|---|
Change | +0.48% |
1-year price change | +13.97% |
Inventiva is a biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. The group is develop ...
Capitalization | 188 M USD |
---|---|
Change | +3.93% |
1-year price change | -19.29% |
Gelesis Holdings, Inc. is a commercial stage biotherapeutics company built for consumer engagement. The Company focuses on advancing superabsorbent hydrogel therapeutics for chronic gastrointestinal (GI) diseases including excess weight, type two diabetes ...
Capitalization | 73 USD |
---|---|
Change | -99.99% |
1-year price change | -99.93% |
Hepion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of drug therapy for treatment of chronic liver diseases. The Company is developing a treatment for non-alcoholic steatohepatitis (NASH), hepatocellular c ...
Capitalization | 7 M USD |
---|---|
Change | +1.61% |
1-year price change | -61.11% |
Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted ste ...
Capitalization | 2 M USD |
---|---|
Change | +1.65% |
1-year price change | -18.66% |
Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company. The Company is focused on advancing novel therapeutics targeting retinal degenerative eye disease, such as atrophic age-related macular degeneration (AMD), and autosomal reces ...
Capitalization | 1 458 M USD |
---|---|
Change | +0.41% |
1-year price change | +6.99% |
Tapinator, Inc. develops and publishes games for mobile platforms. The Companyâs portfolio includes over 300 titles that have over 500 million mobile downloads, including games such as Video Poker Classic and Crypto Trillionaire. It publishes two types ...
Capitalization | 1 M USD |
---|---|
Change | -3.85% |
1-year price change | -23.05% |
VALBIOTIS is a French Research & Development company committed to scientific innovation for the prevention and control of metabolic diseases. VALBIOTIS specializes in the development of innovative nutritional solutions for cardio-metabolic disease prevent ...
Capitalization | 67 M USD |
---|---|
Change | -1.27% |
1-year price change | -22.20% |
Galectin Therapeutics, Inc. is a clinical stage biopharmaceutical company dedicated to developing novel therapies to improve the lives of patients with chronic liver disease and cancer. The Company's drug candidates are based on its method of targeting ga ...
Capitalization | 168 M USD |
---|---|
Change | -.--% |
1-year price change | +63.86% |
89bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The Companyâs lead product candidate, pegozafermin, a speci ...
Capitalization | 776 M USD |
---|---|
Change | +1.41% |
1-year price change | -29.36% |
Lipocine Inc. is a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery to develop differentiated products for Central Nervous System (CNS) disorders. Its clinical development can ...
Capitalization | 37 M USD |
---|---|
Change | -0.14% |
1-year price change | +148.03% |
Marvel Biosciences Corp. is a Canada-based pre-clinical-stage pharmaceutical development biotechnology company. The Company develops new synthetic chemical derivatives of the original approved drug for the new disease indication. It has developed several ...
Capitalization | 3 M USD |
---|---|
Change | -4.55% |
1-year price change | +31.25% |
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunode ...
Capitalization | 58 M USD |
---|---|
Change | -1.16% |
1-year price change | -20.09% |
Ukrproduct Group Limited is a Jersey-based holding company for a group of food and beverage businesses located in Ukraine. The principal activities of the Company are the production and distribution of branded dairy foods and beverages (kvass) in Ukraine ...
Capitalization | 2 M USD |
---|---|
Change | -.--% |
1-year price change | -.--% |
Catalyst Biosciences, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of Hydronidone for the treatment of nonalcoholic steatohepatitis (NASH), a severe form of nonalcoholic fatty liver disease in the Un ...
Capitalization | 19 M USD |
---|---|
Change | +9.13% |
1-year price change | +48.12% |
Biostax Corp. is a developer and marketer of pharmaceutical, biotechnology, and MedTech products. The Company has partnerships in the fields of autoimmunity and immune restoration and are able to deliver solutions today for people that are living with aut ...
Capitalization | 3 M USD |
---|---|
Change | +6.06% |
1-year price change | -52.05% |
Vectus Biosystems Limited is an Australia-based drug discovery and development company. The Company focuses on medical research and development. It is engaged in developing a treatment for fibrosis and high blood pressure, which includes the treatment for ...
Capitalization | 5 M USD |
---|---|
Change | -.--% |
1-year price change | -56.67% |
Thiogenesis Therapeutics, Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing thiol-active therapeutic compounds, which are prodrugs used to treat unmet pediatric medical needs. The Companyâs lead compo ...
Capitalization | 23 M USD |
---|---|
Change | +1.45% |
1-year price change | -6.67% |
Pliant Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapies for the treatment of fibrosis and related diseases. Its lead product candidate, bexotegrast (PLN-74809), is an oral, small ...
Capitalization | 732 M USD |
---|---|
Change | -0.33% |
1-year price change | -33.02% |
LIN BIOSCIENCE, INC. is a Taiwan-based company mainly engaged in the development of new pharmaceutical drugs. The Company is in the research and development and clinical trials stage. It has four major drugs in development, including LBS-008, LBS-007, LBS ...
Capitalization | 222 M USD |
---|---|
Change | -0.43% |
1-year price change | -19.47% |
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), infl ...
Capitalization | 3 M USD |
---|---|
Change | +3.23% |
1-year price change | +146.15% |
Agentix Corp. is a clinical-stage biotechnology company. The Company is engaged in developing therapeutic agents for the treatment of metabolic diseases like Type 2 diabetes mellitus, obesity, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic st ...
Capitalization | 1 M USD |
---|---|
Change | +54.13% |
1-year price change | +14.52% |
Oramed Pharmaceuticals Inc. is a pharmaceutical company engaged in the research and development of pharmaceutical solutions with a technology platform. The Company has developed an oral dosage form intended to withstand the harsh environment of the stomac ...
Capitalization | 89 M USD |
---|---|
Change | -2.68% |
1-year price change | -5.63% |
Syntara Limited, formerly Pharmaxis Ltd, is an Australia-based clinical-stage drug development company with a focus on blood-related cancers. The Companyâs highly productive drug discovery engine is driven by its expertise in amine oxidase inhibitors. I ...
Capitalization | 16 M USD |
---|---|
Change | -.--% |
1-year price change | -.--% |
Lexington Gold Ltd is a gold exploration and development company. It holds interests in four diverse gold projects, covering a combined area of approximately 1,675 acres in North and South Carolina, United States and in five gold projects covering approxi ...
Capitalization | 22 M USD |
---|---|
Change | -.--% |
1-year price change | +9.52% |
Callinex Mines Inc. is a Canada-based company. The Company is advancing its portfolio of base and precious metals-rich deposits located in Canadian mining jurisdictions. The focus of the portfolio is the Rainbow and Alchemist deposits at its volcanogenic ...
Capitalization | 20 M USD |
---|---|
Change | +11.19% |
1-year price change | -10.67% |
Siam Sport Syndicate Public Company Limited is a Thailand-based company engaged in producing and selling of sport and entertainment media. The Company provides various types of media and related activities, including daily newspapers, sport and entertainm ...
Capitalization | 898 848 USD |
---|---|
Change | - |
1-year price change | - |
- Stock Market
- Advanced search
- Kevin Nash
- Company Profiles